{"id":{"repo_id":"loma-linda","oai_identifier":"oai:scholarsrepository.llu.edu:etd-1037"},"canonical_url":"https://search.dev.ndltd.org/etd/loma-linda/oai:scholarsrepository.llu.edu:etd-1037","repository":{"repo_id":"loma-linda","name":"Loma Linda University","base_url":"https://scholarsrepository.llu.edu/do/oai/"},"display":{"title":"Biochemical and Functional characterization of the LEDGF/p75-MeCP2 Interaction in Tumor Cells","abstract":"The lens epithelial derived growth factor p75 (LEDGF/p75) is a novel pro-survival and stress-inducible transcription co-activator that protects mammalian cells from various environmental stresses such as oxidative stress, heat shock, and serum starvation. This emerging cancer-related protein is highly expressed in prostate tumors and other tumor types and promotes resistance to chemotherapy in cancer cells. LEDGF/p75 is also involved in acquired immunodeficiency syndrome (AIDS) since it interacts with HIV-1 integrase to facilitate the integration and replication of the HIV virus in human cells. In addition, LEDGF/p75 has been shown to interact with MLL (mixed lineage leukemia)/menin transcription complex in leukemia cells to facilitate the transcription of cancer-associated genes and leukemic transformation. In order to understand the mechanisms by which LEDGF/p75 contributes to cancer development, we explored its interactions with other transcription factors and the influence of these interactions on its transcriptional activity. Using complementary molecular, biochemical, and cellular approaches we discovered that the amino-terminal region of LEDGF/p75 interacts with the transcription regulator and methylation associated protein MeCP2 in prostate cancer cells and other cancer cell types. We observed that both proteins regulate the expression of the heat shock protein 27 gene by transactivating its promoter region. We propose that the interaction between LEDGF/p75 and MeCP2 modulates the expression of cancer-associated genes in response to environmental stressors. These findings provide a plausible mechanism that can be targeted for the treatment of advanced prostate cancer, which is the second leading cause of cancer deaths in the United States, with a disproportional burden among African American men.","abstract_html":"The lens epithelial derived growth factor p75 (LEDGF/p75) is a novel pro-survival and stress-inducible transcription co-activator that protects mammalian cells from various environmental stresses such as oxidative stress, heat shock, and serum starvation. This emerging cancer-related protein is highly expressed in prostate tumors and other tumor types and promotes resistance to chemotherapy in cancer cells. LEDGF/p75 is also involved in acquired immunodeficiency syndrome (AIDS) since it interacts with HIV-1 integrase to facilitate the integration and replication of the HIV virus in human cells. In addition, LEDGF/p75 has been shown to interact with MLL (mixed lineage leukemia)/menin transcription complex in leukemia cells to facilitate the transcription of cancer-associated genes and leukemic transformation. In order to understand the mechanisms by which LEDGF/p75 contributes to cancer development, we explored its interactions with other transcription factors and the influence of these interactions on its transcriptional activity. Using complementary molecular, biochemical, and cellular approaches we discovered that the amino-terminal region of LEDGF/p75 interacts with the transcription regulator and methylation associated protein MeCP2 in prostate cancer cells and other cancer cell types. We observed that both proteins regulate the expression of the heat shock protein 27 gene by transactivating its promoter region. We propose that the interaction between LEDGF/p75 and MeCP2 modulates the expression of cancer-associated genes in response to environmental stressors. These findings provide a plausible mechanism that can be targeted for the treatment of advanced prostate cancer, which is the second leading cause of cancer deaths in the United States, with a disproportional burden among African American men.","abstract_has_math":false,"creators":["Leoh, Lai Sum"],"institution":null,"degree_name":"Doctor of Philosophy (PhD)","degree_level":"Dissertation","degree_discipline":"Basic Sciences","degree_department":null,"school":null,"contributors":["Casiano, Carlos A.","Duerksen Hughes, Penelope","Linkhart, Thomas A.","Strong, Donna D.","Wall, Nathan R."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-09-01T07:00:00Z","date_published":"2011-09-01T07:00:00Z","updated_at":"2026-07-24T02:52:08Z","subjects":["Medical Genetics","Medical Microbiology","Prostatic Neoplasms - Microbiology; Antigens, Tumor-Associated;","Lens Epithelial Derived Growth Factor p75","LEDGF/p75","Cancer-related proteins","Acquired Immunodeficiency Syndrome","AIDS","Mixed Lineage Leukemia","Prostate Cancer","African-American Males"],"languages":["English"],"rights":["This title appears here courtesy of the author, who has granted Loma Linda University a limited, non-exclusive right to make this publication available to the public. The author retains all other copyrights."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://scholarsrepository.llu.edu/etd/38","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Casiano, Carlos A.","Duerksen Hughes, Penelope","Linkhart, Thomas A.","Strong, Donna D.","Wall, Nathan R."]},{"key":"dc:creator","label":"Author","values":["Leoh, Lai Sum"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"thesis:degree_discipline","label":"Discipline","values":["Basic Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medical Genetics","Medical Microbiology","Prostatic Neoplasms - Microbiology; Antigens, Tumor-Associated;","Lens Epithelial Derived Growth Factor p75","LEDGF/p75","Cancer-related proteins","Acquired Immunodeficiency Syndrome","AIDS","Mixed Lineage Leukemia","Prostate Cancer","African-American Males"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["This title appears here courtesy of the author, who has granted Loma Linda University a limited, non-exclusive right to make this publication available to the public. The author retains all other copyrights."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://scholarsrepository.llu.edu/etd/38"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The lens epithelial derived growth factor p75 (LEDGF/p75) is a novel pro-survival and stress-inducible transcription co-activator that protects mammalian cells from various environmental stresses such as oxidative stress, heat shock, and serum starvation. This emerging cancer-related protein is highly expressed in prostate tumors and other tumor types and promotes resistance to chemotherapy in cancer cells. LEDGF/p75 is also involved in acquired immunodeficiency syndrome (AIDS) since it interacts with HIV-1 integrase to facilitate the integration and replication of the HIV virus in human cells. In addition, LEDGF/p75 has been shown to interact with MLL (mixed lineage leukemia)/menin transcription complex in leukemia cells to facilitate the transcription of cancer-associated genes and leukemic transformation. In order to understand the mechanisms by which LEDGF/p75 contributes to cancer development, we explored its interactions with other transcription factors and the influence of these interactions on its transcriptional activity. Using complementary molecular, biochemical, and cellular approaches we discovered that the amino-terminal region of LEDGF/p75 interacts with the transcription regulator and methylation associated protein MeCP2 in prostate cancer cells and other cancer cell types. We observed that both proteins regulate the expression of the heat shock protein 27 gene by transactivating its promoter region. We propose that the interaction between LEDGF/p75 and MeCP2 modulates the expression of cancer-associated genes in response to environmental stressors. These findings provide a plausible mechanism that can be targeted for the treatment of advanced prostate cancer, which is the second leading cause of cancer deaths in the United States, with a disproportional burden among African American men."]},{"key":"dc:title","label":"Title","values":["Biochemical and Functional characterization of the LEDGF/p75-MeCP2 Interaction in Tumor Cells"]}]}],"canonical_facts":{"dc:contributor":["Casiano, Carlos A.","Duerksen Hughes, Penelope","Linkhart, Thomas A.","Strong, Donna D.","Wall, Nathan R."],"dc:creator":["Leoh, Lai Sum"],"dc:description.abstract":["The lens epithelial derived growth factor p75 (LEDGF/p75) is a novel pro-survival and stress-inducible transcription co-activator that protects mammalian cells from various environmental stresses such as oxidative stress, heat shock, and serum starvation. This emerging cancer-related protein is highly expressed in prostate tumors and other tumor types and promotes resistance to chemotherapy in cancer cells. LEDGF/p75 is also involved in acquired immunodeficiency syndrome (AIDS) since it interacts with HIV-1 integrase to facilitate the integration and replication of the HIV virus in human cells. In addition, LEDGF/p75 has been shown to interact with MLL (mixed lineage leukemia)/menin transcription complex in leukemia cells to facilitate the transcription of cancer-associated genes and leukemic transformation. In order to understand the mechanisms by which LEDGF/p75 contributes to cancer development, we explored its interactions with other transcription factors and the influence of these interactions on its transcriptional activity. Using complementary molecular, biochemical, and cellular approaches we discovered that the amino-terminal region of LEDGF/p75 interacts with the transcription regulator and methylation associated protein MeCP2 in prostate cancer cells and other cancer cell types. We observed that both proteins regulate the expression of the heat shock protein 27 gene by transactivating its promoter region. We propose that the interaction between LEDGF/p75 and MeCP2 modulates the expression of cancer-associated genes in response to environmental stressors. These findings provide a plausible mechanism that can be targeted for the treatment of advanced prostate cancer, which is the second leading cause of cancer deaths in the United States, with a disproportional burden among African American men."],"dc:identifier":["https://scholarsrepository.llu.edu/etd/38"],"dc:language":["English"],"dc:rights":["This title appears here courtesy of the author, who has granted Loma Linda University a limited, non-exclusive right to make this publication available to the public. The author retains all other copyrights."],"dc:subject":["Medical Genetics","Medical Microbiology","Prostatic Neoplasms - Microbiology; Antigens, Tumor-Associated;","Lens Epithelial Derived Growth Factor p75","LEDGF/p75","Cancer-related proteins","Acquired Immunodeficiency Syndrome","AIDS","Mixed Lineage Leukemia","Prostate Cancer","African-American Males"],"dc:title":["Biochemical and Functional characterization of the LEDGF/p75-MeCP2 Interaction in Tumor Cells"],"thesis:degree_discipline":["Basic Sciences"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Doctor of Philosophy (PhD)"]},"updated_at":"2026-07-24T02:52:08Z"}